Frank Dekker partner in funded Horizon Europe project
The team of Prof. Frank Dekker of the Groningen Research Institute of Pharmacy (GRIP) participates in a Horizon Europe project that was recently funded. The project is called 'In Armor' and concerns the pre-clinical development of small molecule inhibitors of histone lysine deacetylases (HDAC) for the induction of antimicrobial peptides. The project will be performed by a consortium of 16 participants from 11 different European countries with a total budget of EUR 6 million. The Dekker team is funded with EUR 390,000 to work on the synthesis and characterization of a focussed collection of HDAC inhibitors that will be taken into pre-clinical development.
| Last modified: | 15 June 2023 4.23 p.m. |
More news
-
16 September 2025
The ocean absorbs carbon from the air, but what if the temperature increases?
‘Fortunately, seawater absorbs carbon dioxide (CO₂). If it didn’t, things would have been over and done with already,’ according to climate and ocean researchers Richard Bintanja and Rob Middag. But what actually happens to the ocean's carbon...
-
10 September 2025
Funding for Feringa and Minnaard from National Growth Fund project Big Chemistry
Two UG research projects have received funding from the National Growth Fund project Big Chemistry via NWO.
-
09 September 2025
The carbon cycle as Earth’s thermostat
Earth's natural carbon cycle becomes unbalanced if we, humans, continue to release extra carbon dioxide (CO2) into the atmosphere. In this overview article about the carbon cycle, you can find out how Earth generally keeps itself in balance and how...